Cargando…

Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT in patients with gastric MALT lymphoma without high-grade transformation

The purpose of this retrospective study was to investigate the role in staging and prognostic value of pretherapeutic fluorine-18-fluorodeoxyglucose (F-18 FDG) positron emission tomography (PET)/computed tomography (CT) in patients with gastric mucosa-associated lymphoid tissue (MALT) lymphoma witho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Yong-Jin, Hyun, Seung Hyup, Moon, Seung Hwan, Lee, Kyung-Han, Min, Byung Hoon, Lee, Jun Haeng, Kim, Won Seog, Kim, Seok Jin, Choi, Joon Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084924/ https://www.ncbi.nlm.nih.gov/pubmed/33927319 http://dx.doi.org/10.1038/s41598-021-88815-2

Ejemplares similares

Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal Cancer
por: Le Thiec, Maelle, et al.
Publicado: (2020)

Role of (18)F-FDG PET Scans in Patients with Helicobacter pylori-Infected Gastric Low-Grade MALT Lymphoma
por: Song, Kyung Ho, et al.
Publicado: (2011)

Prognostic value of pretherapeutic FDG PET/CT in non-small cell lung cancer with pulmonary lymphangitic carcinomatosis
por: Park, Yong-Jin, et al.
Publicado: (2023)

CONSORT-Independent prognostic value of asphericity of pretherapeutic F-18 FDG uptake by primary tumors in patients with breast cancer
por: Jung, Ji-hoon, et al.
Publicado: (2017)

Is There a Role for [(18)F]FDG PET-CT in Staging MALT Lymphoma?
por: Cohen, Dan, et al.
Publicado: (2022)

Whole-body MRI versus (18)F-FDG PET/CT for pretherapeutic assessment and staging of lymphoma: a meta-analysis
por: Wang, Danyang, et al.
Publicado: (2018)

Role of F-18 FDG PET/CT in non-conjunctival origin ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphomas
por: Park, Hye Lim, et al.
Publicado: (2019)

Prognostic Value of Pretherapeutic Primary Tumor MTV from [(18)F]FDG PET in Radically Treated Cervical Cancer Patients
por: Cegla, Paulina, et al.
Publicado: (2021)

Metabolic bulk volume from FDG PET as an independent predictor of progression-free survival in follicular lymphoma
por: So, Heejune, et al.
Publicado: (2023)

Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin’s lymphoma
por: Rogasch, Julian M. M., et al.
Publicado: (2018)

Cluster analysis of autoencoder-extracted FDG PET/CT features identifies multiple myeloma patients with poor prognosis
por: Lee, Hyunjong, et al.
Publicado: (2023)

Prognostic Value of Volume-Based (18)F-Fluorodeoxyglucose PET/CT Parameters in Patients with Clinically Node-Negative Oral Tongue Squamous Cell Carcinoma
por: Lee, Su Jin, et al.
Publicado: (2012)

Volumetric and texture analysis of pretherapeutic (18)F-FDG PET can predict overall survival in medullary thyroid cancer patients treated with Vandetanib
por: Werner, Rudolf A., et al.
Publicado: (2018)

Pretherapeutic Assessment of Pancreatic Cancer: Comparison of FDG PET/CT Plus Delayed PET/MR and Contrast-Enhanced CT/MR
por: Zhang, Zaizhu, et al.
Publicado: (2022)

(18)F-FDG PET versus (18)F-FDG PET/CT for Adrenal Gland Lesion Characterization: a Comparison of Diagnostic Efficacy in Lung Cancer Patients
por: Sung, Yon Mi, et al.
Publicado: (2008)

Cerebellum/liver index in pretherapeutic (18)F-FDG PET/CT as a predictive marker of progression-free survival in follicular lymphoma treated by immunochemotherapy and rituximab maintenance
por: Godard, François, et al.
Publicado: (2022)

Pretherapeutic Imaging for Axillary Staging in Breast Cancer: A Systematic Review and Meta-Analysis of Ultrasound, MRI and FDG PET
por: Le Boulc’h, Morwenn, et al.
Publicado: (2021)

Prognostic significance of preoperative (18)F-FDG PET/CT in uterine leiomyosarcoma
por: Park, Jeong-Yeol, et al.
Publicado: (2017)

High-grade Hepatic Mucosa-associated Lymphoid Tissue (MALT) Lymphoma Probably Transformed from the Low-grade Gastric MALT Lymphoma
por: Chung, Yong Woo, et al.
Publicado: (2006)

Metabolism-Associated Gene Signatures for FDG Avidity on PET/CT and Prognostic Validation in Hepatocellular Carcinoma
por: Lee, Hyunjong, et al.
Publicado: (2022)

Quantitative assessment of the asphericity of pretherapeutic FDG uptake as an independent predictor of outcome in NSCLC
por: Apostolova, Ivayla, et al.
Publicado: (2014)

Striatofrontal Deafferentiation in MSA-P: Evaluation with [(18)F]FDG Brain PET
por: Kim, Hae Won, et al.
Publicado: (2017)

Primary Malt Lymphoma of the Common Bile Duct
por: Cho, Young Hoon, et al.
Publicado: (2013)

Metabolic activity of extranodal NK/T cell lymphoma on (18)F-FDG PET/CT according to immune subtyping
por: Lim, Chae Hong, et al.
Publicado: (2021)

Impact of suboptimal dosimetric coverage of pretherapeutic 18F-FDG PET/CT hotspots on outcome in patients with locally advanced cervical cancer treated with chemoradiotherapy followed by brachytherapy
por: Lucia, François, et al.
Publicado: (2020)

Prediction of Central Nervous System Relapse of Diffuse Large B-Cell Lymphoma Using Pretherapeutic [(18)F]2-Fluoro-2-Deoxyglucose (FDG) Positron Emission Tomography/Computed Tomography
por: Song, Yoo Sung, et al.
Publicado: (2015)

Body Mass Index with Tumor (18)F-FDG Uptake Improves Risk Stratification in Patients with Breast Cancer
por: Hyun, Seung Hyup, et al.
Publicado: (2016)

A Machine Learning Approach Using FDG PET-Based Radiomics for Prediction of Tumor Mutational Burden and Prognosis in Stage IV Colorectal Cancer
por: Lee, Hyunjong, et al.
Publicado: (2023)

The Value of (18)F-FDG PET/CT Imaging Combined With Pretherapeutic Ki67 for Early Prediction of Pathologic Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
por: Luo, Jurui, et al.
Publicado: (2016)

(18)F-FDG PET Metabolic Parameters and MRI Perfusion and Diffusion Parameters in Hepatocellular Carcinoma: A Preliminary Study
por: Ahn, Sung Jun, et al.
Publicado: (2013)

Primary Pulmonary Low-Grade Angiosarcoma Characterized by Mismatch between (18)F-FDG PET and Dynamic Contrast-Enhanced CT
por: Kim, Eun Young, et al.
Publicado: (2015)

Prediction of Pathologic Grade and Prognosis in Mucoepidermoid Carcinoma of the Lung Using (18)F-FDG PET/CT
por: Park, Byungjoon, et al.
Publicado: (2015)

Conjunctival MALT Lymphoma: Utility of FDG PET/CT for Diagnosis, Staging, and Evaluation of Treatment Response
por: Sallak, Asmaa, et al.
Publicado: (2014)

The Highest Metabolic Activity on FDG PET Is Associated With Overall Survival in Limited-Stage Small-Cell Lung Cancer
por: Kwon, Soo Hyun, et al.
Publicado: (2016)

Role of (18)F-FDG PET/CT in patients without known primary malignancy with skeletal lesions suspicious for cancer metastasis
por: Park, Soo Bin, et al.
Publicado: (2018)

Does Delayed-Time-Point Imaging Improve 18F-FDG-PET in Patients With MALT Lymphoma?: Observations in a Series of 13 Patients
por: Mayerhoefer, Marius E., et al.
Publicado: (2016)

(18)F-FDG PET/CT for staging and response assessment of primary parotid MALT lymphoma with multiple sites involvement: A case report
por: Ren, Yixuan, et al.
Publicado: (2019)

Diagnostic value of (18)F-FDG PET/CT in discriminating between benign and malignant lesions of the ribs
por: Choi, Sunju, et al.
Publicado: (2022)

The prognostic value of radiomic features from pre- and post-treatment (18)F-FDG PET imaging in patients with nasopharyngeal carcinoma
por: Kim, Soo Jeong, et al.
Publicado: (2023)

Prognostic value of pretreatment (18)F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma
por: Jo, In Young, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lfp1l07fsjuobv6bbdn9d2v5ft